Symbio, Global Clinical Research Organization, Announces Two Key Leadership Appointments | PR Newswire [Video]

, /PRNewswire/ — Symbio, the global specialist therapeutic clinical research organization, is pleased to announce two key leadership appointments.

Symbio, the global specialist therapeutic clinical research organization, announces two key leadership appointments.

Shanna Smith is appointed Chief Commercial Officer. Shanna has a 16-year tenure with Symbio and brings an extensive background in crafting customer solutions in both clinical operations and commercial functions. She has played a pivotal role in driving Symbio’s growth and commitment to quality, building outstanding relationships with clients and investigators, and expanding Symbio’s global presence.

Patrick Ronanis appointed to the Board of Directors of Symbio. Patrick currently serves as an Operating Partner at ARCHIMED, a global investment firm focused on the healthcare industries. He is the former CEO of two life sciences firms, Validant (now Eliquent Life Sciences) and Greenleaf Health, which he founded in 2007. Prior to this, Patrick served as VP Regulatory Policy & External Affairs at Novartis …